The University of Chicago Header Logo

Connection

Sonali Smith to Lymphoma, Mantle-Cell

Back to Details
This is a "connection" page, showing publications Sonali Smith has written about Lymphoma, Mantle-Cell.
Sonali Smith
Connection Strength
1.054
Lymphoma, Mantle-Cell
  1. Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials. Lancet Haematol. 2017 Apr; 4(4):e176-e182.
    View in: PubMed
    Score: 0.562
  2. Targeting mTOR in mantle cell lymphoma: current and future directions. Best Pract Res Clin Haematol. 2012 Jun; 25(2):175-83.
    View in: PubMed
    Score: 0.402
  3. Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium. J Clin Oncol. 2010 Nov 01; 28(31):4740-6.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.